Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2025-12-24 @ 11:57 PM
NCT ID:
NCT00002951
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically or cytologically confirmed diagnosis of carcinoma
* Stage II-III (T2, T3, N0 or T1-3, N1) carcinoma of head and neck, including: oral cavity, pharynx, larynx, paranasal sinuses, and cervical esophagus
* No N2 or N3
* Measurable disease is not required
PATIENT CHARACTERISTICS:
Age:
* Not specified
Performance status:
* Zubrod 0-3
Life expectancy:
* Anticipated survival is 3-4 years (median)
Hematopoietic:
* WBC count at least 3.5/mm\^3
* Platelet count at least 100,000/mm\^3
Hepatic:
* Not specified
Renal:
* Not specified
Cardiovascular:
* Not specified
Pulmonary:
* Not specified
Other:
* No infection or severe medical illness
* Not pregnant
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* No prior chemotherapy
Endocrine therapy:
* Not specified
Radiotherapy:
* No prior radiotherapy
Surgery:
* No prior surgery
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00002951
Study Brief:
Protocol Section:
NCT00002951